Related Experiment Video
Updated: May 19, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development
1Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Cancer Management and Research
|August 21, 2012
Summary
Prostate cancer virulence involves interactions between cancer cells and their microenvironment, particularly the bone. Understanding these complex relationships aids in developing new therapies for aggressive prostate cancer.
Area of Science:
- Oncology
- Cancer Biology
- Microenvironment Research
Background:
- Prostate cancer progression involves complex interactions beyond epithelial cells, including stromal cells and the extracellular matrix.
- Prostate cancer preferentially metastasizes to bone, highlighting the critical role of the bone microenvironment.
Purpose of the Study:
- To elucidate the mechanisms driving virulent prostate cancer development.
- To understand the specific interactions between prostate cancer cells and the bone microenvironment.
- To identify novel therapeutic targets based on these interactions.
Main Methods:
- Analysis of signaling pathways in prostate cancer epithelial cells and the bone microenvironment.
- Investigating the role of dysregulated developmental pathways in cancer progression.
- Examining the impact of microenvironment interactions on tumor growth, invasion, and immune surveillance.
Main Results:
- Dysregulation of normal prostate and bone development pathways contributes to cancer virulence.
- Microenvironment interactions promote excessive cell growth, neovascularization, and invasiveness.
- These interactions can weaken antitumor immune responses and lead to castrate-resistant disease.
Conclusions:
- Virulent prostate cancer development is a multifaceted process involving the tumor microenvironment.
- Targeting the interplay between cancer cells and organ-specific microenvironments offers a promising therapeutic strategy.
- Further research into these complex relationships can lead to novel treatments for advanced prostate cancer.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...